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Preface
We are pleased to publish two essays 
presented at that symposium: the pungent
and remarkable essay by Leonard Hayflick,
pioneering gerontologist who has made
many scientific contributions but whose
name is forever associated with the limits
of cell replication—the Hayflick Limit;
and the sophisticated and shrewd 
observations by philosopher and writer,
Harry Moody, Jr.
Robert N. Butler, M.D.
President and CEO
International Longevity Center-USA
A t the 2002 annual meeting of theGerontological Society of America,a symposium was held with 
the provocative title “Has Anyone Ever 
Died of Old Age?” Sponsored by the
International Longevity Center-USA, it
drew participants from a variety of disciplines
into a lively discussion relating to our 
need to understand the underlying biology
of aging that predisposes us to death.
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IT’S ILLEGAL TO DIE OF OLD AGE 
The answer to the question posed by this sympo-
sium title is easy to give. Since 1951, no one 
in the United States has died of “old age” because
“old age” was cured in that year.
The cure resulted from a Public Health Conference
on Records and Statistics in which all state and
federal agencies were ordered to adopt a standard
list of 130 contributing and underlying causes 
of death.1 In 1951, the list deleted a cause of
death attributed to “old age.”
Thus, with a single stroke of a typewriter key, old
age was cured as a cause of death in this country.
Because death certificates are legal documents,
you should be advised that should you wish to die
of old age it is illegal in this country. It is also not
legally possible for you to die of a broken heart
nor are you allowed to die laughing. However, if
you insist on dying of old age, there are a few 
foreign countries in which you can legally do so.
The standard list of causes of death has been
revised several times since 1952, and, effective
with deaths in 1999, the United States began
using the tenth revision of the International
Statistical Classification of Diseases and Related
Health Problems, called the ICD-10.2 So,
for the last 50 years no one in the United States
has died legally of old age.
However, if you would like to be executed in the
United States, you are within the law because 
it is legal to die in the electric chair or by lethal 
injection, the euphemism for which appears in the 
ICD-10 as cause 109—“legal intervention.”
So by committing an act that is illegal you can
achieve a death that is legal. Is this a great 
country or what?
A MODEST PROPOSAL FOR ELIMINATING 
THE LEADING CAUSES OF DEATH 
I propose that this unique method of curing 
causes of death be implemented for resolving the
leading causes of death in this country. For 
example, if we would agree to delete cardiovascular
disease from the standard list of causes of death
we would immediately gain seven years in life
expectancy, save billions of dollars in medical
costs, eliminate much misery, force many pharma-
ceutical companies into bankruptcy and drive
thousands of cardiologists and cardiovascular 
surgeons into unemployment lines.
Now, if you think that you can dodge the 
prohibition on dying from old age by choosing to
die from “natural causes”—forget it. You can’t 
do that either. Just as it’s illegal to die of “old
age,” it’s also illegal to die from “natural causes.”
About 15 years ago I speculated in print why 
natural causes disappeared as a cause of death in
the United States. I remembered that as a boy 
I had heard of people dying from natural causes;
yet as an adult I had never heard of anyone dying
from natural causes. What mystified me was how
a major cause of death could have been resolved
without my knowing the biological basis for 
its resolution. I speculated that the discoverers 
of the cure for natural causes were very modest 
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scientists. No one could recall their names, they
didn’t publish their work, the Nobel Prize 
committee ignored them, and they achieved their
monumental success with no grant support.
Now, I have found a simpler answer to my 
question. All you have to do to eliminate a cause 
of death in this country is simply to have it
deleted from the ICD.
WHAT CAUSED THE 1998 ALZHEIMER’S 
DISEASE EPIDEMIC?
It is also possible to do the reverse of eliminating
a cause of death. That is, it is legal to make
deaths from a disease increase. This magic was
performed four years ago. In the year 1998, there
occurred a 55 percent increase in deaths from
Alzheimer’s disease in the United States. I will
quote from the U.S. National Vital Statistics
Report of May 2001 in which you will find a
description of exactly how to increase deaths
from a disease without requiring an epidemic.3 
“In absolute terms, over 10,000 more deaths were
classified to Alzheimer’s disease in ICD-10 than
in (the earlier) ICD-9. Nearly all of this increase
(about 95 percent) comes from deaths classified
in ICD-9 as Presenile dementia (290.1). In
ICD-9 a definitive diagnosis was required for
classification as Alzheimer’s disease. Terms such
as ‘Alzheimer’s-type dementia’ or ‘Alzheimer’s
dementia’ were classified as Presenile dementia
rather than Alzheimer’s disease. In addition,
in ICD-9 if an unspecified organic psychotic 
condition (294.9) is mentioned with Alzheimer’s
disease, the two conditions form a linkage and
are coded to 290.1 (Presenile dementia). Under
ICD-10 this linkage does not exist, strictures
regarding definitive diagnosis are relaxed,
and thus any mention of Alzheimer’s disease is
classified as Alzheimer’s disease (G30). This
involves the reclassification of nearly all cases of
Presenile dementia to Alzheimer’s disease.”
So, this is how by the stroke of a few keyboard
keys 10,000 new cases of Alzheimer’s 
disease deaths suddenly appeared in 1998 and
have continued annually since that date.
NO ONE DIES FROM ANY OF THE LEADING
CAUSES OF DEATH
The statisticians would have you believe that
older people must die from a particular pathology,
but I am one of a very few biologists who believe
the opposite. That is, I believe that older people
do not die from any of the 130 legal causes 
specified by the statisticians.
Here’s why: Most of the biomedical community
believes, to the point of uttering it as a mantra,
that the major risk factor that contributes to the
leading causes of death—cardiovascular disease,
stroke, and cancer—is the aging process. In fact,
I have argued that no one arbitrarily over, say,
the age of 75 has ever died from any of the 130
causes on the ICD. What people over the 
age of 75 do die from is the continuous loss of 
physiological capacity that is the hallmark 
of the aging process and that increases their 
vulnerability to the leading causes of death. Two-
thirds of people over the age of 75 will die from
one of the three leading causes of death. By 
this reasoning the ultimate cause of death for
everybody over age 75 is, in fact, “old age” or
“natural causes.” What is legally written 
on the death certificates of old people is simply
irrelevant detail.
The biological evidence that the direct cause of
all deaths in old age is the aging process is 
incontrovertible, but the statisticians seem to 
be unaware of this. The statisticians are not 
alone in their misunderstanding. They have been
joined by most of the biomedical community,
who are dedicated to the proposition that the study
of the leading risk factor for death—the aging
process—is unimportant. The irony is that
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despite the belief of most biomedical professionals
that the greatest risk factor for the leading causes
of death is the aging process, the resources 
that they have decided to devote to understanding 
the aging process are microscopic compared 
to the resources made available for the study of 
age-associated diseases.
This discrepancy in funding is indefensible
because the unifying concept that underlies the
etiology of all of the leading causes of death 
is the fact that old cells are more vulnerable to
pathology than young cells. Thus, the fundamental
question that is rarely addressed, and for which
few resources are made available, is this: Why are
old cells more vulnerable to pathology than 
young cells?
UNDERSTANDING AGING IS NOT DEPENDENT
ON RESOLVING AGE-ASSOCIATED DISEASES 
What are the consequences of our present policy
of devoting most of our resources to an under-
standing of age-associated diseases? Of the
several major consequences, one is that we might
resolve all of the leading causes of death in 
old age and thereby force most physicians, bio-
medical researchers and all geriatricians into 
an unemployment line. With respect to the
increase in life expectancy that this monumental 
achievement would produce, an increase of about
15 years would occur.
What then would be the cause of deaths? The
ICD would now have to be modified to reveal
only one cause of death for those over age 75—
namely, old age. Thus, having resolved the leading
causes of death we will then have revealed the
underlying cause of all deaths in old age—the
aging process. For the first time in human history,
most people will be found to die of old age.
What the biomedical community does not realize 
is that the resolution of age-associated diseases 
will advance our knowledge of aging processes 
to the same extent that the resolution of 
pediatric-associated diseases, such as poliomyelitis,
acute lymphocytic leukemia, Wilms’ tumors, and
iron deficiency anemia, increased our knowledge 
of childhood development; that is, no increase 
in knowledge occurred at all.
The aging process is not a disease so the probability
of resolving it as a cause of death is, in my view,
close to zero. It is close to zero because even with
the most advanced technology known today,
we cannot control the rate of aging in something
as infinitely less complicated as our own 
automobiles. Even the desirability of having the
power to interfere with the aging process is filled
with unintended consequences, a subject 
that, although peripheral to the subject of this 
discourse, has been discussed elsewhere.4,5
The distinction between aging and disease is 
central to understanding why the resolution of the
leading causes of death in old age will tell us little
about the fundamental biology of age changes.4,5
Aging is not a disease because, unlike any disease,
age changes 1 occur in every animal that reaches a
fixed size in adulthood;2 unlike any disease,
age changes cross virtually every species barrier;3
unlike any disease, age changes occur in all 
animals that reach a fixed size in adulthood and
only after sexual maturation;4 unlike any disease,
age changes occur in animals removed from 
the wild and protected by humans, even when
that species has not been known to experience
aging for thousands or millions of years;5 unlike
any disease, age changes increase vulnerability 
to death in 100 percent of the animals in which it
occurs;6 and unlike any disease, age changes occur
in both animate and inanimate objects.
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THE UNRELIABILITY OF 
DEATH-CERTIFICATE DATA
In the minds of most of the public, policymakers
and many biomedical scientists, no one suffers or
dies from aging. We suffer and die from the 
diseases associated with the aging process. Yet,
age changes are the cause of the increased 
vulnerability to everything that is written on the
death certificates of the elderly.
How reliable are the legal causes of death currently
written on death certificates? The fact is that
there are multiple pathologies in older people so
the true cause of death in old people is rarely
known. This fact is substantially ignored by those
who depend slavishly on the statistics that rely 
on what is written on death certificates. Because
there are few autopsies and little research on the
etiology of death in older people, the cause of
most deaths in old age is still hidden in the
proverbial black box. The numbers of autopsies
that have been done on the elderly have continued
to decrease in the last few decades. And the small
number of autopsies that have been done is
inversely proportional to age. In those rare
instances where autopsies have been performed
on a large number of old people, the findings
have shown that from 40 percent to 50 percent of
the causes of death appearing on the death 
certificates have been inaccurate.6-8 In the most
recent study of 93 postmortem examinations done
in an Israeli hospital over a 20-year period,
42 percent of the causes of death written on the
death certificates were incorrect.9 Over this 
20-year period the rate of autopsies dropped from
2.8 percent to 0.25 percent. These findings 
should cause considerable concern for the many 
political, economic, actuarial, and scientific 
decisions that, without benefit of autopsy, may
have a 40 percent error rate.
Both lay and science policymakers, properly
impressed with the future demographics of the
graying of all economically developed countries,
are basing important policies and decisions 
on a flawed understanding of what constitutes
aging research and what the results of that
research might accomplish.
Understanding how the molecules of an old cell
differ from those in a young cell and how those 
differences lead to pathology has the potential to
increase our understanding of the etiology of 
cancer, cardiovascular disease, stroke, and even 
age-related accidents because the etiology of all of
these conditions is rooted in those differences.
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“DID ANYBODY EVER DIE OF OLD AGE?” 
Logically, there are two answers to this question:
Yes and no. Both could imply the “end of aging 
as we know it,” and the question itself has
assumed controversial status.1,2 Thus, if we answer
the question with:
(1) Yes, people do die of old age, it means aging 
is a disease, so let’s find a cure for it. (And people
will live indefinitely.)
(2) No, it means people die of some other disease,
so let’s find a cure for those diseases. (And people
will live indefinitely.)
Hmmm. Peculiar answers to what may be a 
peculiar question. Let’s examine these answers—
yes and no—in terms of the logic of their 
presuppositions and their implications for research
about aging. We will find that approaching the
question, “Did anybody ever die of old age?”
raises, in turn, profound questions about geronto-
logical research, about fate and accident, and 
even about the human condition itself, questions
with a long and venerable history.3 
AGING IS A DISEASE 
First let’s examine “Yes, … aging is a disease.”
Admittedly, it is peculiar to speak of aging itself
as a “disease.” Mainstream gerontology has spent
a generation or two drumming into everyone’s
head the dogma that “aging isn’t a disease, but it
increases our susceptibility to disease,” etc.4,5 But
refusing to call aging a “disease” is a presupposition
we could change.6,7 The fact that aging is 
familiar and “normal” (as in “normal aging”) doesn’t
mean we can’t declare it to be a disease and
change our linguistic habits. We could begin to
change our ordinary language this way, just as we
do when we speak of insomnia as a disease or
alcoholism as a disease.
To think of aging as a disease becomes the strategy
for “anti-aging medicine,” which may not now be
a legitimate clinical field but could become an
agenda for legitimate research in biogerontology.8
Indeed, some advocates of “transhumanism” in
ethics argue strongly that life extension and even
immortality should become our explicit research
agenda. To call aging a disease isn’t a description
of current language so much as it is a decision
about how we’re going to use language. Ordinary
language, like scientific language, can change over
time. But the decision here has a big consequence,
and the consequence is that we begin to think 
of aging as a condition that can be changed, even
altered or abolished, just as one might imagine a
cure for progeria (a disease that causes accelerated
aging in childhood).
CURE DISEASES ONE BY ONE 
This first conclusion—aging is a disease—will be
unpalatable to many, especially those who accept
Dying From Old Age: 
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mainstream gerontology’s opinion on the matter.
So let’s take the second alternative—that nobody
ever died of old age. Ironically, by following 
this answer we might end up with a life-extension
strategy not very different from that urged by
radical advocates of life extension. We might
decide that because aging isn’t a disease, nothing
prevents us, in theory, from eliminating all causes
of death, permitting people to live indefinitely.
Thus, we also reach the radical life-extension
point of view by the opposite logical route. But
note in this view we would get there only 
incrementally, as ethicist John Harris has suggested.
That is, we would, step by step, eliminate distinc-
tive diseases of old age and, step by step, push
back life expectancy at every age, without limit.
Now what happens if we follow this second 
strategy? Here we must have recourse to 
rudimentary epidemiology. In the short run, the
results are disappointing. Even if we cured the big
killers (heart disease, cancer, and stroke) average
life expectancy in the population would only rise
12 years or so (from 77 to 89 in the United
States). The reason is that once we save people
from dying of one disease, they die of another
disease. So we try the following thought experi-
ment: What happens if we could cure (or prevent)
all diseases? Answer: People would die from acci-
dents. Again and again in theoretical gerontology
we come back to the comparative role of fate and
accident in shaping the limits of life. It turns 
out, as the authors of Greek tragedy understood,
that fate and accident are intertwined in 
mysterious ways.
To understand why, consider a prosaic example.
Note that the sigmoid (S-shaped) curve for the
“life expectancy” of drinking glasses in a restau-
rant actually resembles the same formal curve as
we observe for death rates in populations: the
familiar life tables of demography. Of course, we
might succeed in shifting the curve or modifying
its shape by various preventive medical interven-
tions. We could push the curve to the right 
(compression of morbidity and mortality); we can
even displace it substantially to the right by big
medical breakthroughs. Still, the glasses would
continue to break by chance (accident) at various
times, some early, some late, and before long we’re
back to the familiar sigmoid curve again.
Here we reach the heart of the matter. These 
incremental moves—a disease-by-disease strategy
toward indefinite life—don’t get us very far
because human bodies, like drinking glasses, are
still vulnerable and subject to accidents. To
change the role of accident, we will have to dig
deeper, to the level of “fate”: that is, what makes
drinking glasses (or human bodies) subject to 
statistically predictable accident curves? Along
these lines, Jay Olshansky9 and others have 
argued that any strategy for health promotion
will have only minimal effects on average 
life expectancy and maximum lifespan unless 
we have a deeper understanding of the biology 
of aging itself.
THE BASIC QUESTION: WHAT IS AGING? 
So we come to the inescapable question: What is
aging? Evidently, the answer is not simply
chronological passage of time but rather what we
sometimes call “biological aging”—some 
underlying process, perhaps the same process 
that is modified (but not eliminated) by caloric
restriction, which is the sole proven intervention
for lifespan prolongation.
But to refer to a technology or mode of interven-
tion (like caloric reduction) explains nothing.
We might therefore be tempted to think of aging
in more analytic or mathematical terms. Thus,
one definition of aging might be “increasing
probability of death [the Gompertz curve] along
with impairment of function” with advancing
time. The trouble with this approach is that it
6
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doesn’t explain anything either. “Increasing 
probability” after all doesn’t actually cause any-
thing. We need to find some specific reason for
this “impairment of function”: for example, a 
link to immune function or some other physio-
logical failure that could be the basis of increasing 
probability of death.
Think of the aging body in comparison to an
aging car or aging aircraft and consider the 
engineering concept of “mean time to failure.”
Just as aging aircraft are more vulnerable, so are
aging bodies. But, again, mean time to failure
doesn’t cause anything; it’s just another statistical
statement about probable longevity, in aircraft 
or organic systems.
The difference is that biological systems, unlike
other natural objects such as a car or an aircraft,
have within them a capacity for repair and 
regeneration. Along these lines, Plato gave the
example of an old coat, constantly repaired, its
material components always changing but its
identity of form remaining the same. So, too,
repair mechanisms at the cellular and molecular
level give formal continuity, “sameness,” to the
human body.
If we define aging as “impaired function with
increased probability of death,” then we need to
look at the case of animals that do not age, such
as the hydra or sea anemone, which regenerates
itself (through budding) and shows a constant
(not increasing) probability of death from preda-
tors, accidents, and the like. The hydra, then, is
not immortal—that is, it is not invulnerable. But
it lives indefinitely, which is the desired outcome
for the life-extension strategy.
So we have come some distance in understanding
the logic of the question “Did anybody ever die 
of old age?,” and we understand something of the
conceptual alternatives entailed by the question.
It is not formal or statistical description or
redescription that we need but a better causal
understanding of the process of aging itself.
To push matters further, let us distinguish here
between proximate and underlying causes. Here 
I want to argue that the question “Did anybody
ever die of old age?” is logically ambiguous
because it entails different kinds of causality.
To understand the causal logic involved, compare
our question to another question: “Did anybody
ever die of AIDS?” Now, we could reasonably
answer, “No, nobody ever died of AIDS because
AIDS is simply a progressive collapse of immune
function.” Thus, people don’t die of “impaired
immune function,” they die from an opportunistic
infection or from a cancer or other organ failure,
but not from AIDS itself.
This would be a logical answer, but it’s an
implausible one: a bit like saying, “Guns don’t kill
people, people kill people.” The statement may 
be literally true, but it’s not very helpful because 
the proximate cause (a firearm) only becomes
effective when someone actually shoots the gun.
In the same way, rare forms of pneumonia kill
patients who have been compromised by AIDS.
We wouldn’t want to say, “Nobody ever died of
AIDS” and therefore devote all our research
efforts to finding cures for specific opportunistic
infections that end up on the death certificates 
of some AIDS patients.
Thus, as with AIDS, the answer to the question
“Did anybody ever die of old age?” is both yes and
no, because old age only “kills” when conjoined
with some specific (proximate) cause.
Conceived in this way, the strategy for curing AIDS
becomes comparable to the strategy for “curing”
aging: namely, eliminate those factors that permit
proximate causes to be fatal.
Here lies the strategy for regenerative medicine 
that could permit organisms to regenerate 
themselves like sea anemones do. It may be that
in coming generations stem-cell research will 
provide clues that permit regenerative medicine to
become the reality for which so-called anti-aging
medicine is only a simulacrum.
THE ILLUSION OF IMMORTALITY 
Now we come to the big question, the one that
animates this entire agenda. Suppose our strategy
for regenerative medicine succeeds. Suppose we
“cured” aging itself? Would we live forever—
or at least indefinitely? What would happen if we
could maintain the human body at its maximum
or optimal state of regeneration? Here John
Harris,10 citing the work of Tom Kirkwood,
argues that we would not live forever but rather
for a very long time. Kirkwood suggests we 
could say just how long by looking at the body of
an 11-year-old, the time in life when regenerative
(healing) capacity as at its natural maximum.
Using this example—imagining we are all 
11-year-olds forever—actuarial calculations sug-
gest that we could conceivably live for 1,200 years.
What would kill us? Alas, accidents. Whether
human or sea anemone, disease is not the only
thing that causes death. But, as I’ve suggested, the
very term “accident” is just another way of
describing an inherent vulnerability of the organic
system. Consider again the drinking glasses in the
restaurant. The “aging” of those drinking glasses 
is another way to speak about mean time to 
failure. But no specific glass ever breaks from
mean time to failure, the glass always breaks for
some specific cause that shatters it.
Following the sigmoid curve, eventually all the
glasses do break. But they wouldn’t break at all if
they were made of, say, stainless steel. Made 
differently, they could escape vulnerability. So too,
if the human body were made of a biological 
equivalent of stainless steel, we too could escape
vulnerability. True, drinking glasses made of 
stainless steel wouldn’t be “glasses” in the ordinary
sense of the word. But they might function 
perfectly well as drinking vessels.
So too if human bodies were reengineered not 
simply by regenerative medicine (to be like 
11-year-olds, very long-lived) but for far, far
greater regenerative capacities, then we too might
live much, much longer. Here lies another strategy
for the hypothetical science of life extension: artifi-
cial organs and systems stronger than our own.
We might begin by perfecting the artificial heart.
Nobody ever died of old age in the same way 
that nobody’s heart ever stopped because of
impaired cardiac function. There will always be
some specific cause—some coronary obstruction,
arrhythmia, whatever. A generic term like “heart
failure” simply describes the weakening of a
capacity to resist or recover from a specific cause
that stops the heart from beating. But is heart
failure ever a cause of death? According to the
line I have argued here, perhaps not. In the entire
discussion so far, we’ve offered different defini-
tions of aging but we haven’t defined death,
so I will now offer one. In How We Die,11 Sherwin
Nuland argues that all deaths are caused by loss of
blood supply to the brain.
DISPOSABLE SOMA 
No matter what scenario of life extension we
adopt, it’s hard to imagine circumstances in which
the brain is absolutely invulnerable to loss of
blood supply by some biological or accidental
catastrophe. Brain vulnerability stands as an 
ultimate barrier to life-extension technology.
Maybe the conclusion is that we are all simply
“disposable soma,” to use the phrase from
Kirkwood’s memorable theory about the genetics
of aging.12 In that case we could achieve a kind of
immortality through the germ line (living on
through our successors), which is the kind of
immortality many believe in today. But if we want
8
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9to preserve our individuality, we have to preserve
our cognitive uniqueness and history, that is,
preserve the information properties of the human
brain. Do we then “download” onto a computer,
as some transhumanists and science-fiction writers
have suggested?13 The only scenario where 
the brain would be invulnerable would be one in
which we have downloaded its contents onto
some backup system, perhaps along the lines
anticipated by Kurzweil.14
We now pass beyond the bounds of biogerontology
and enter into more turbulent waters of mind-
body questions and murky matters of individual
identity, questions perhaps best left to fiction
writers and theologians. If we eliminate aging,
would we eliminate altogether what we under-
stand, however dimly, as the human condition?15
What is clear enough is that pushed to the
extreme, a question like “Did anybody ever die of
old age?” raises profound questions about our
human condition and about steps toward
“enhancement” of what we accept as our human
condition, including the life cycle itself.16,17
As I write this manuscript on my computer I am
filled with a sudden panic because I realize that
I’ve forgotten to back it up. Suppose my computer
were to fail, and everything I’ve written were lost?
Perhaps that panic is a little like sudden death:
the recognition of vulnerability and realization
that everything can disappear in a flash. Until we
are able to download ourselves (and would it 
really be ourselves?), we will probably have to live
with that vulnerability, which so far at least seems
to be part of our human condition.
References
1. Moody, H.R. 2001–2002. Who’s afraid of life 
extension? Generations 25: 33–37.
2. Olshansky, S.J., Hayflick, L., Carnes, B.A. 2002.
No truth to the fountain of youth. Scientific American 286:
92–95.
3. Gruman, Gerald. 2003. A History of Ideas About the
Prolongation of Life. New York: Springer.
4. Austad, Steven. 1999. Why We Age. New York: Wiley.
5. Hayflick, Leonard. 1994. How and Why We Age.
New York: Ballantine.
6. Caplan, Arthur. 1992. Is aging a disease? In Arthur
Caplan, If I Were a Rich Man Could I Buy a Pancreas? And
Other Essays on the Ethics of Health Care. Bloomington:
Indiana University Press.
7. Murphy, T.F. 1986. Cure for Aging? Journal of Medicine
and Philosophy 11 (3): 237–255.
8. de Grey, A.D.N.J., Ames, B.N., Andersen, J.K., Bartke,
A., Campisi, J., Heward, C.B., et al. 2002. Time to Talk
SENS: Critiquing the Immutability of Human Aging.
Annals of the New York Academy of Sciences 959: 452–62.
9. Olshansky, S.J., Carnes, B.A. 2001. The Quest for
Immortality: Science at the Frontiers of Aging.
New York: Norton.
10. Harris, John. 2002. “Intimations of Immortality: The
Ethics and Justice of Life Extending Therapies,” Hatch
Lecture. Mt. Sinai School of Medicine and International
Longevity Center.
11. Nuland, S. 1995. How We Die. New York: Vintage.
12. Kirkwood, Tom. 1999. The Time of Our Lives.
New York: Oxford University Press.
13. Dewedney, Christopher. 1998. Last Flesh: Life in the
Transhuman Era. HarperCollins-Canada.
14. Kurzweil, Ray. 2000. The Age of Spiritual Machines:
When Computers Exceed Human Intelligence.
New York: Penguin.
15. Kass, Leon R. 2001. L’Chaim and its limits: why not
immortality? First Things 113: 17–24.
16. Parens, Erik (ed.). 1998. Enhancing Human Traits:
Ethical and Social Implications. Washington: Georgetown
University Press.
17. President’s Council on Bioethics: Staff Working 
Paper. 2003. “Age-Retardation: Scientific Possibilities 
and Moral Challenges.” http://www.bioethics.gov/
background/age_retardation.html
ILC Occasional Paper: Has Anyone Ever Died of Old Age?
Leonard Hayflick is an internationally renowned
scientist, who, in 1962, overturned scientific
dogma with his discovery that, contrary to what
had been believed since 1900, cultured normal
human cells have a limited capacity for replication.
This phenomenon is known as “The Hayflick
Limit.” His discovery that mortal and immortal
mammalian cells exist became the basis for much
of modern cancer research. He suggested that 
the finite replicative capacity of cultured normal
human and animal cells is the in vitro expression
of aging and longevity determination.
Dr. Hayflick also developed the first normal
human diploid cell strain (WI-38) that is used
worldwide wherever cultured normal human cells
are required. He proved the safety and efficacy 
of the first poliomyelitis vaccine produced 
in WI-38. Today most of the world’s human 
virus vaccines are produced in WI-38 or similar 
cell strains. Hayflick also discovered the cause 
of primary atypical pneumonia (“Walking
Pneumonia”) in humans to be a mycoplasma,
the smallest free-living micro-organism.
Dr. Hayflick is the author of over 250 scientific
papers, book chapters and edited books, of 
which four papers are among the 100 most cited 
scientific papers of the two million papers
published in the basic biomedical sciences from
1961 to 1978. He is the author of the popular
book How and Why We Age, published in 1994 
by Ballantine Books and translated into 
nine languages.
Dr. Hayflick is currently professor of anatomy 
at the University of California, San Francisco. He
received his Ph.D. from the University of
Pennsylvania in 1956.
Harry R. Moody is senior associate at the
International Longevity Center, where 
he is director of the Institute for Human Values
in Aging.
Dr. Moody, a philosopher by background, is 
the author of many articles and books in 
gerontology on applied ethics, the humanities 
and arts, and the search for meaning in later life.
Dr. Moody was national program director of 
the Robert Wood Johnson Foundation’s Faith 
in Action Programs and executive director of the
Brookdale Center on Aging.
Dr. Moody received his Ph.D. from 
Columbia University.
ILC Occasional Paper: Has Anyone Ever Died of Old Age?
About the Authors
INTERNATIONAL LONGEVITY CENTER–USA
Board of Directors
Laurance S. Rockefeller, Honorary Chair
Robert N. Butler, M.D., ILC–USA
Mary Carswell
Christine K. Cassel, M.D.
Everette E. Dennis, Ph.D.
Susan W. Dryfoos
Lloyd Frank
Annie Glenn
Senator John Glenn
Lawrence K. Grossman
Raymond L. Handlan
Robert D. Hormats
Tasneem Ismailji, M.D.
Rose Kleiner (1925-2001)
Linda P. Lambert
Max Link, Ph.D., Chair
William C. Martin
Evelyn Stefansson Nef
Stanley B. Prusiner, M.D.
Albert L. Siu, M.D., M.S.P.H.
Joseph E. Smith
Jackson T. Stephens, Jr.
Catharine R. Stimpson, Ph.D.
James H. Stone
William D. Zabel, Esq.
Mel Zuckerman
John F. Zweig
ILC International Centers
Directors
Robert N. Butler, M.D., ILC–USA
Shigeo Morioka, ILC–Japan
Françoise Forette, M.D., ILC–France
Baroness Sally Greengross, ILC–United Kingdom
Rosy Pereyra Ariza, M.D., ILC–Dominican Republic
ILC Occasional Paper: Has Anyone Ever Died of Old Age?

60 East 86th Street
New York, NY 10028
212 288 1468 Tel
212 288 3132 Fax
www.ilcusa.org
An Affiliate of Mount Sinai School of Medicine OP01-2003
R
INTERNATIONAL LONGEVITY CENTER–USA
H
as
 A
ny
on
e 
Ev
er
 D
ie
d 
of
 O
ld
 A
ge
?
